2/253/655091988 |
您所在的位置：网站首页 › 2/253/655091988 |
data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/37925144Clinical Response and Remission in Patients With Severe …网页Anti-Asthmatic Agents. Biological Products. Clinical response was achieved in most adult patients initiating biologic therapy, and clinical remission was observed in 19% of the patients following 12 months of treatment. Further studies are required to assess the long-term outcome of achieving clinical remission with biologic therapy.
发布时间：2024-07-07data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/20144356Noninvasive glucose monitoring: a novel approach - PubMed网页2009年3月1日 · By using a combination of (three) independent technologies-ultrasonic, electromagnetic, and thermal-GlucoTrack presents a unique approach for a real-time, truly NI blood glucose spot measurement. Methods: Clinical trials were performed in two stages. Stage 1 was an initial method validation and performance verification of the device.
发布时间：2024-07-07data-id="" iid="">Quran.comhttps://quran.com/2:253Surah Al-Baqarah - 253 - Quran.com网页We have chosen some of those messengers above others. 1 Allah spoke directly to some, and raised some high in rank. To Jesus, son of Mary, We gave clear proofs and supported him with the holy spirit. 2 If Allah had willed, succeeding generations would not have fought ˹among themselves˺ after receiving the clear proofs. But they differed—some believed …
发布时间：2024-07-07data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/26650336Validation of a Method to Identify Immunocompromised …网页Rationale: Immunocompromised patients are at high risk for developing severe sepsis. Currently, there are no validated strategies for identifying this group of patients in large administrative databases. Objectives: We set out to define and validate a method that could be used to identify immunocompromised patients with severe sepsis in administrative …
发布时间：2024-07-07